Gabriella joined the group in March 2022, moving from the University of Genoa where she received her PhD in Chemical Sciences and Technologies. In collaboration with IAMA therapeutics, she is now working on the design, synthesis and structure activity-relationship studies of small molecules to develop new potential drugs for neurodevelopmental disorders treatment.
Research center
CHT@Erzelli
About
Colleagues of Molecular Modeling and Drug Discovery
